|
FRMD4B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.438100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.590590E-04 |
| Normal-vs-Stage2 |
3.084400E-01 |
| Normal-vs-Stage3 |
4.523400E-01 |
| Normal-vs-Stage4 |
8.707000E-01 |
| Stage1-vs-Stage2 |
2.608000E-01 |
| Stage1-vs-Stage3 |
1.589670E-02 |
| Stage1-vs-Stage4 |
3.559900E-03 |
| Stage2-vs-Stage3 |
6.029600E-01 |
| Stage2-vs-Stage4 |
3.950000E-01 |
| Stage3-vs-Stage4 |
6.286400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.071500E-02 |
| Normal-vs-AfricanAmerican |
1.672430E-01 |
| Normal-vs-Asian |
1.691220E-01 |
| Caucasian-vs-AfricanAmerican |
9.403800E-01 |
| Caucasian-vs-Asian |
1.250170E-01 |
| AfricanAmerican-vs-Asian |
1.922810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.299200E-01 |
| Normal-vs-Female |
2.03089999999406E-05 |
| Male-vs-Female |
4.440300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.861400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.811800E-04 |
| Normal-vs-Age(61-80Yrs) |
6.086400E-02 |
| Normal-vs-Age(81-100Yrs) |
6.883000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.150220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.259000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.643800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.062150E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.810000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.457600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.717100E-03 |
| Normal-vs-Grade 2 |
4.03130000000695E-05 |
| Normal-vs-Grade 3 |
1.055760E-01 |
| Normal-vs-Grade 4 |
8.830500E-02 |
| Grade 1-vs-Grade 2 |
3.176000E-02 |
| Grade 1-vs-Grade 3 |
2.593200E-04 |
| Grade 1-vs-Grade 4 |
4.63169999997959E-06 |
| Grade 2-vs-Grade 3 |
5.916600E-03 |
| Grade 2-vs-Grade 4 |
9.50380000031004E-07 |
| Grade 3-vs-Grade 4 |
3.178700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.32729996069759E-09 |
| Normal-vs-ccB subtype |
6.460800E-01 |
| ccA subtype-vs-ccB subtype |
1.23159999976252E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.212100E-02 |
| Normal-vs-N1 |
6.387600E-01 |
| N0-vs-N1 |
7.317800E-01 |
|
|
